Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPENTOLATE Cause Psychomotor hyperactivity? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Psychomotor hyperactivity have been filed in association with CYCLOPENTOLATE (Cyclopentolate Hydrochloride). This represents 1.0% of all adverse event reports for CYCLOPENTOLATE.

6
Reports of Psychomotor hyperactivity with CYCLOPENTOLATE
1.0%
of all CYCLOPENTOLATE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Psychomotor hyperactivity From CYCLOPENTOLATE?

Of the 6 reports, 3 (50.0%) required hospitalization.

Is Psychomotor hyperactivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPENTOLATE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPENTOLATE Cause?

Mydriasis (55) Eye pain (41) Vision blurred (39) Drug ineffective (38) Keratopathy (37) Visual impairment (36) Headache (34) Nausea (32) Confusional state (31) Toxic anterior segment syndrome (31)

What Other Drugs Cause Psychomotor hyperactivity?

METHYLPHENIDATE (617) QUETIAPINE (412) ARIPIPRAZOLE (389) OLANZAPINE (366) SERTRALINE (288) MONTELUKAST (282) RISPERIDONE (277) LEVETIRACETAM (247) VENLAFAXINE (214) LEVOTHYROXINE (211)

Which CYCLOPENTOLATE Alternatives Have Lower Psychomotor hyperactivity Risk?

CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPENTOLATE vs CYCLOSERINE

Related Pages

CYCLOPENTOLATE Full Profile All Psychomotor hyperactivity Reports All Drugs Causing Psychomotor hyperactivity CYCLOPENTOLATE Demographics